Steering Committee

  • Margaret Chren, MD

    San Francisco, CA Dr. Chren is a health services investigator, internist, and dermatologist who is Director of the HSR&D Research Enhancement Award Program (REAP) at the San Francisco VAMC, and Professor in Residence, University of California at San Francisco. As Director of the SFVAMC REAP ( http://www.sfhsrd.research.va.gov ), she oversees a multidisciplinary research initiative that provides a cohesive research environment for over 15 VA-based health services researchers. Research mentoring is an important part of Dr. Chren's efforts, and she holds an NIH Mid-Career Investigator Award (K24) to develop and mentor junior investigators in patient-based research. Her own research focuses on understanding, measuring, and improving comprehensive health outcomes of patients with chronic diseases. She has previously developed and validated a skin-related quality-of-life tool, Skindex, which is widely used as a dermatologic outcomes measure, and has been translated and adapted into over 15 languages. Her current studies measure complex health attributes (such as patients' experience of illness, their preferences, and quality of life), as well as more conventional clinical assessments, to compare effectiveness of different therapies for common diseases. For example, she directs a prospective study of a large cohort of patients diagnosed with nonmelanoma skin cancer (the most common malignancy), to determine long-term outcomes after different treatments

  • Bruce E. Strober, MD PhD

    New York, NY Dr. Strober is an associate professor in the Department of Dermatology at the University of Connecticut School of Medicine. He received his medical and graduate degrees from Columbia University College of Physicians and Surgeons and completed his postgraduate training in dermatology at New York University. Dr. Strober is board certified by the American Board of Dermatology, a fellow of the American Academy of Dermatology, and a member of the medical board of the National Psoriasis Foundation. Dr. Strober has authored numerous journal articles and has spoken extensively to both physician and patient audiences in the field of dermatology. He directs the Clinical Trials Unit in the Department of Dermatology, where he is involved with many clinical trials for the development of therapies to treat psoriasis and psoriatic arthritis. Dr. Strober also regularly sees patients at the University of Connecticut where he specializes in general medical dermatology.

  • Kevin Cooper, MD

    Cleveland, OH Dr. Kevin D. Cooper is the Professor and Chair of the Department of Dermatology at Case Western Reserve University (CWRU) and University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio. He is a Staff Physician for the Dermatology Service at the Cleveland VA Hospital. Dr. Cooper is the Director of the NIAMS Skin Diseases Research Center at CWRU, focusing on creating advances in skin diseases. He also directs the UHCMC Murdough Family Center for Psoriasis and the NIAMS Psoriasis Center of Research Translation (CORT) at CWRU. Dr. Cooper joined CWRU and UHCMC from prior positions at the University of Michigan and the National Institutes of Health, following dermatology training at Oregon Health Sciences University and medical school at the University of Florida. He enjoys mentoring faculty, residents, fellows, and students. Dr. Cooper is the elected President of the Council of Clinical Chairs at CWRU and UHCMC (2007-present), and is a member of the Boards of Trustees for UHCMC and University Hospitals Medical Group. Dr. Cooper is currently President of the Association of Professors of Dermatology, Past President of the Society for Investigative Dermatology, and has chaired a number of American Academy of Dermatology Committees and Councils, including the Scientific Assembly Committee. An author on over 300 publications and chapters, Dr. Cooper serves on NIH Advisory Groups and NIH review panels. He has previously organized the annual meeting Programs for the APD, the AAD, the ADA, and the Symposium for Biology of the Skin.

  • Abrar A. Qureshi, MD MPH

    Boston, MA Dr. Abrar Qureshi is an Assistant Professor of Dermatology at Harvard Medical School and Vice-Chair of the Department of Dermatology, Brigham and Women’s Hospital, Boston, MA. He trained at the Harvard School of Public Health immediately after his clinical dermatology training, supported via a NIAMS/Herzog Foundation F32 followed by a Dermatology Foundation Career Development Award, and is currently in his last year of his K07 award from the NCI. Dr. Qureshi's major effort is in the epidemiology laboratory where he is Director of the Clinical Research Program of the Department of Dermatology and Associate Epidemiologist at the Channing Laboratory, work that is supported via grants from the National Institutes of Health in the area of skin cancer. His research interests are translational, bridging epidemiology and outcomes research combined with study of biomarkers and genomics to answer important research questions. His research focus in psoriasis stems from his clinical interests as Co-Director of the Center for Skin and Related Musculoskeletal Diseases that he founded in 2003, caring for patients with severe psoriasis and psoriatic arthritis. Bringing his skill-set in molecular/genetic epidemiology from skin cancer to the study of psoriasis and its co-morbidities is already resulting in manuscripts published in high impact journals and success in collaborating with large national and international consortia.

  • Andrew Blauvelt, MD

    Dr. Blauvelt is Professor in the Departments of Dermatology and Molecular Microbiology & Immunology at Oregon Health & Science University. He is the Founder and Director of OHSU's Center of Excellence for Psoriasis and Psoriatic Arthritis, a regional referral center specializing in multi-disciplinary care of patients with complex psoriasis. Dr. Blauvelt is also Principal Investigator on numerous psoriasis clinical trials at OHSU. He also serves as member of the Medical Advisory Board of the National Psoriasis Foundation. In addition, Dr. Blauvelt is an accomplished immunologist, having been honored for his past basic science research work by election into the American Society for Clinical Investigation, a premier organization for physician-scientists.